How Is AL Amyloidosis Currently Treated?

Morie Gertz, MD, Hematologist, Chair Emeritus Internal Medicine, Mayo Clinic, gives an overview of immunoglobulin light chain-associated (AL) amyloidosis and how the disease is currently managed.
As Dr. Gertz explains, AL amyloidosis is a rare blood disorder associated with the overproduction of amyloid, which leads to the deterioration of vital organs, most notably the heart, kidneys, and liver. The heterogeneity of this disease makes it difficult to diagnose and treat. There is no genetic predisposition for AL amyloidosis nor are there specific environmental factors associated with the disease.